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The Study of NF-κB Peptide Mimics and How Proteins Bind DNA  
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Honors in Chemistry 
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ABSTRACT 
The protein complex nuclear factor kappa B (NF-κB) is widely considered to be 
one of the most influential transcription factors when studying cellular functions. Peptide 
mimics of NF-κB aim to inhibit DNA binding in order to displace the natural 
transcription factor, therefore inhibiting transcription and translation. In theory, NF-κB is 
not the problem; the real problem lies in directing the synthesis and expression of harmful 
proteins. In conjunction with this, the project aims to study NF-κB and its structure and 
function to determine what criteria are important for the binding of DNA in order to 
design a peptide that comes closer to this goal of producing a mimic of NF-κB. To 
accomplish this, peptides were designed, synthesized, cleaved, dissolved, and purified in 
order to run mass spectrometry to determine whether the correct peptides were 
synthesized. Overall, if peptide mimics are more successful in binding DNA than NF-κB, 
then the research could potentially be used in clinical settings in order to prevent the 
overexpression of particular genes implicated in various diseases. 
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Introduction 
The protein complex nuclear factor kappa B (NF-κB) is widely considered to be 
one of the most influential and important transcription factors when studying cellular 
functions such as immune response, cell growth, and development.1 A transcription factor 
is a protein that binds to specific DNA sequences in order to control transcriptional 
regulation. Typically, transcription factors are comprised of both repression and 
activation domains that are used to turn genes on or off on the DNA strand.2 NF-κB in 
particular is well-studied because the transcription factors encompassing it play a vital 
role in the regulation of the body’s response to infection. The erroneous regulation of NF-
κB has been linked to carcinogenesis, epilepsy, 
and other serious neurological and 
neurodegenerative disorders.3 Understanding of 
the structure of NF-κB and how it binds is 
necessary to understand the function. The NF-
κB proteins bind to DNA to regulate the 
transcriptional silencing of specific genes. 
Specifically, NF-κB typically binds to DNA with a 
looped region of amino acids off of a beta (β) sheet.1 
This binding region contains a β-hairpin, a β-sheet 
containing two β-strands that are linked to make up 
this looped region.  
 
 
Figure 1.  NF-κB protein 
binding DNA.  This shows 
both the p50 subunit and the 
p65 subunits of the NF-κB 
protein and how it binds to 
helical DNA using a β-hairpin 
region.1 
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In order for the peptide to truly be a mimic of NF-κB, the structure and 
composition must be similar.  Research has been done to determine the crystal structure 
of NF-κB to study what truly causes the binding. From many previous studies, it has been 
determined that not only is the composition of DNA binding regions of proteins 
important, but the structure is also crucial for DNA binding. Although it is true that the 
mimic must be composed of similar amino acids, it must also have structural integrity.4 
With the knowledge that the peptide binds using a β-hairpin region, the structure of 
synthesized peptide mimics will be verified in order to maintain the proper structure, 
even when amino acids are substituted.  
In order to determine how to create mimics of NF-κB that will displace the natural 
transcription factors, prior studies have to be considered to learn how NF-κB binds and 
functions. In one study, it was acknowledged that NF-κB is a highly regulated 
transcription complex. Comprised of subunits, the two most widely known are the p50 
and p65 subunits.5 The two different subunits bind to the DNA differently, but there are 
significant similarities in the binding. Both subunits bind most notably using arginine, 
tyrosine, glutamine, histidine, and lysine, although these are located in different positions 
for the two subunits.1 This knowledge is important when studying the mimics of NF-κB, 
because intertwining high levels of these specific amino acids in the mimics should allow 
for a higher binding affinity.  
In an additional study, the variations of the dynamics of NF-κB were studied. 
From this study, it was determined that different members of the same family of NF-κB 
proteins bind different DNA sequences differently.6 This presents the high level of 
variation that comes with studying NF-κB, as some versions may bind one form of DNA 
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better than another form. While this can make studying the protein more difficult, it can 
also present further research options. If one synthesized peptide type may not bind a 
specific DNA type well, there might be other applications for the synthesized peptide in 
other DNA applications in the future. 
The overall goal is to inhibit DNA binding in order to displace the natural 
transcription factor and therefore inhibit transcription and translation. In theory, NF-κB is 
not the problem; the real problem lies in directing the synthesis and expression of harmful 
proteins. In conjunction with this, this project aimed to study NF-κB and its structure and 
function. From this, the criteria that are important for the binding of DNA were studied in 
order to design a peptide that comes closer to this goal of producing a mimic of NF-κB 
and therefore inhibiting it. It is important to regulate gene expression and by successfully 
synthesizing and producing a peptide that does this is the beginning of accomplishing this 
objective.  
 
Methods 
 
Peptide Design 
Table 1. NF-κB Peptide Mimic Sequences  
Mutant Peptide Sequence 1 
(“Original”) 
Pro-Tyr-Leu-Gln-Ile-Arg-Phe-Arg-Val-Asn-Gly-
Lys-Trp-Val-Lys-Pro-Gln-Val-Lys-Ile 
 
NF-κB Peptide Sequence 2 
(“Hybrid”) 
Gln-Arg-Phe-Arg-Trp-Val-Arg-Val-Asn-Gly-
Lys-Tyr-Ile-Lys-Val-Gln-Leu-Glu 
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Figure 2. NF-κB peptide mimic (sequence 1) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. NF-κB peptide mimic (sequence 2) 
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Peptide Synthesis 
The NF-κB binding sequence (Table 1) was synthesized by solid phase peptide 
synthesis using a PS3 Peptide Technologies Peptide Synthesizer. All of the amino acids 
were coupled for 20 minutes before being deprotected in duplicate for 5 minutes using 
20% piperidine. The solvent used throughout this process was DMF and the peptide 
sequence was activated using the activator HBTU. Finally, the peptide was capped using 
acetic anhydride. Once synthesis was complete, the peptide was capped and placed into a 
peptide flask. The peptide was then cleaved from the resin using a cleavage cocktail 
consisting of 95% TFA, 2.5% TIPS and 2.5% water. After complete cleavage, the peptide 
solution was evaporated until a very small volume remained before the peptide was 
precipitated with 20 mL of cold ether. This caused the solution to separate into layers. 
The water layer, which contained the synthesized peptide, was collected and lyophilized 
in order to turn the peptide solution into a powder. 
 
Purification and Desalting 
Once the peptide was lyophilized, the peptide had to be dissolved based on the 
structure and composition of the peptide. A large portion of peptide was dissolved in 
approximately five mL of liquid and filtered. Once filtered, high purification liquid 
chromatography was used to purify the peptide. To do this, a C-18 silica based reversed 
phase high performance liquid chromatography (HPLC) column and two solvents (A & 
B) were used. Solvent A is comprised of 95% HPLC water, 5% Acetonitrile and 0.1% 
TFA, while solvent B is comprised of 95% acetonitrile, 5% HPLC water and 0.1% TFA. 
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The column was washed with solvent A in order to equilibrate the column. The peptide 
was then injected at small amounts to determine elution time, before being washed by 
solvent B. Once the proper elution time was found, the peptide injection amount was 
increased and fractions were collected over the elution time. Once purified, the peptide 
was placed on the lyophilizer in order to turn the peptide solution into powder. Once 
lyophilized, a small amount of each fraction was dissolved into 50 µL of distilled water 
and placed on the MALDI-ToF plate. Once dry, one microliter of matrix was added on 
top. A Bruker Microflex MALDI-ToF mass spectrometer was then used to determine the 
mass of the peptide and whether the fraction contains the correct peptide and is purified 
correctly.  
 Once the peptide and its mass were verified, the peptide was desalted. To do this, 
2 mg of the peptide was dissolved in 300 µL of distilled water. The desalting column was 
washed with 25 mL of distilled water (five column volumes). The 300 µL peptide sample 
was then added to the column and seven fractions were collected. A ten microliter portion 
of each fraction was then diluted to 700 µL total. UV-vis spectroscopy was used to 
determine absorbance of each sample at 280 nm. Like fractions were then combined and 
lyophilized and checked again with MALDI-ToF mass spectrometry to confirm mass.  
 
Circular Dichroism (CD) Analysis 
The structure of the peptide was determined using CD analysis. One milligram of 
peptide was dissolved in one mL of CD buffer (10 mM Na2HPO4). CD was done using a 
temperature interval measurement method in order to determine the secondary structure 
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of the peptide sample. This was done at 25 degrees measuring a wavelength range of 260-
190 nm.  
 
Combining and Annealing DNA 
In order to combine the single-stranded DNA pieces, first the concentrations of 
each had to be determined.  The concentrations of the single strand DNA sequences were 
determined and the two sequences were combined to produce double helix DNA. The 
DNA was annealed by combining and heating at 95°C for five minutes before being 
allowed to cool to room temperature. Once annealed, the absorbance was taken at 260 nm 
to determine the concentration of the DNA sample (table 2).  
 
Fluorescence DNA Binding Study 
 To determine how the peptide samples bind DNA, a fluorescence binding study 
was executed. In this study, peptide concentration was held constant while the amount of 
DNA was increased (table 3). These varying samples were combined with fluorescence 
buffer (10 mM Na2HPO4, 100 mM NaCl) to make a solution of 700 µL total. A 
fluorescence spectrometer was then used to run the study, with each sample being run in 
duplicate for a total of 20 samples. These values were then averaged to get final results.  
 
 
 
    
10 
Results  
Mass spectrometry 
Once the peptide was effectively and correctly synthesized, cleaved, and purified, 
the peptide was desalted to remove the salts and to prepare the sample for further studies. 
Both peptide sequences studied were desalted at different times, but using the same 
desalting column. Once completed and absorbance acquired, like fractions were 
combined and lyophilized. To determine which fractions contained the correct peptide 
(not ionized versions), mass spectrometry was used. Peptide sequence 2 was correctly 
identified by its molecular weight (figure 4) in the fraction containing the most 
lyophilized peptide.  
 
 
 
 
 
 
 
Figure 4. The mass spectrometry graph confirming the mass of peptide sequence 2. The 
graph shows a high peak at 2361.93 and expected weight is 2360.25.  
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Peptide sequence 1 was separated into several fractions. When these fractions 
were analyzed using mass spectrometry, the correct peptide mass (2511.03) was 
identified in fraction two which contained the least peptide, while fraction 1 which 
contained the most peptide when analyzed, had a mass of 2534.66 (figure 5, 6). The 
difference between the theoretical molecular weight of this peptide and the peptide 
fraction with the most volume of desalted peptide is approximately 23 units different. 
Although not completely confirmed, it is believed to be a sodium atom attached to the 
peptide. From previous studies done by our research lab7, it has been determined that 
there are higher levels of sodium in our water. For some reason, high levels of peptide 
sequence 1 after being desalted using deionized water from our lab seem to contain a 
change in molecular weight of approximately 23. This difference in molecular weight is 
currently being studied to determine the causes and what can be done to prevent this 
irrelevant binding in the future. 
 
 
 
 
 
 
Figure 5. The mass spectrometry graph displaying fraction two with a molecular weight 
of 2534.66, approximately 23 different than the theoretical.  
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Figure 6. The mass spectrometry graph confirming the mass of peptide sequence 1. The 
graph shows a high peak at 2512.41 and expected weight is 2511.03. 
 
Circular Dichroism Analysis 
 Once mass spectrometry was completed, circular dichroism (CD) was completed 
on both peptide sequences. Because peptide sequence 1 had issues with molecular 
weight, it was decided that CD analysis would be done on both fractions. When analyzing 
the sequences using CD, we hope to see a spectrum that confirms a beta sheet region 
within the sequence. With peptide sequence 1, the results of fraction 1 (peptide with 
higher molecular weight) confirmed random coil within the peptide sequence, based on 
its minimum peak at 195 nm, which is characteristic of a random coil peptide structure 
(figure 7). It is known that structure is very important to function, therefore the peptide 
sequence being in a random coil configuration points to the possibility that it will not 
bind to DNA as effectively as the NF-κB protein. Fraction 2 in peptide sequence 1 
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seemed to have slightly better results, with a configuration that looks much more like a 
beta sheet, although not fully (figure 8). While this is great for research purposes, it also 
means that the fraction containing the least amount of peptide once desalted has the best 
results out of the two, which is not good when wanting to use the more structured peptide 
for further studies.  
 
 
 
 
 
 
Figure 7. Circular dichroism spectra of peptide sequence 1 (fraction 1) that shows 
evidence of random coil, with no real β-sheet indicated.  
 
 
 
 
Figure 8. Circular dichroism spectra of peptide sequence 1 (fraction 2) that indicates 
random coil, with some β-sheet activity. 
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 Peptide sequence 2, on the other hand, had good results when analyzed with CD. 
The CD analysis spectra showed that the peptide was in a beta sheet configuration, which 
is very similar to the NF-κB protein (figure 9). As it is known how important structure is 
to binding, this led to the conclusion that peptide sequence 2 could present more 
consistent and successful binding patterns when binding studies were completed.  
 
 
 
 
 
 
Figure 9. Circular dichroism spectra of peptide sequence 2 that shows two minima, one 
minima consistent with a beta sheet (minimum at 210-215) and one indicating some 
random coil.  
 
Fluorescence DNA Binding Study 
 Fluorescence studies were then completed to determine which peptides bind DNA 
more successfully.  To do this, first the peptide sample is dissolved into fluorescence 
buffer. Then, the concentrations of peptide and DNA (table 2) were used to complete 
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DNA, then as the amount of DNA increases, the peptide should bind the DNA more and 
therefore the graph should show less fluorescence of peptide due to tryptophan 
fluorescence being quenched by the DNA binding. The spectra created from the results of 
the binding study for peptide sequence 2 shows strong evidence that this sequence 
successfully binds DNA (figure 10, 11).  
 
Table 2. Table displaying values for both peptide and DNA concentrations, along with 
the sequence of the DNA used in the fluorescence binding studies.  
 
Table 3. Table displaying the values of peptide and DNA concentrations for each of the 
fractions used in the fluorescence binding studies. 
Fluorescence Concentration Chart 
Sample  Buffer (μL) Peptide (8μM) DNA (μM) DNA (μL) 
1 779 21 0 0 
2 777 21 2 2 
3 773 21 5 6 
4 767 21 10 12 
5 761 21 15 18 
6 756 21 20 23 
7 750 21 25 29 
8 744 21 30 35 
9 732 21 40 47 
10 709 21 60 70 
Peptide Concentration 
395 μM 
 
DNA Concentration 685 μM 
DNA Sequence 
5’-GGAGTGTCCC-3’ 
3’-CCTCACAGGG-5’ 
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Figure 10. Tryptophan fluorescence quenching of peptide sequence 2 (trial 1) analyzed 
using 8μM peptide and 0 to 50µM DNA.   
Figure 11. Fluorescence binding spectra of peptide sequence 2 (trial 2), presenting 
similar results as trial 1 
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 Fluorescence binding studies have not been completed yet for peptide sequence 1, 
due to insolubility issues in the fluorescence buffer. In the future, the goal is to complete 
this study for this sequence in order to fully compare the two sequences. From this point, 
it is expected that peptide sequence 1 will bind DNA less successfully than peptide 
sequence 2, based on prior knowledge gained from this study, although these suspected 
results cannot be verified fully until binding studies are completed.  
 
Discussion & Conclusion 
 It is known that when analyzing a peptide’s DNA binding affinity, structure is 
very important. Through experimenting with two different peptide mimics of NF-κB, this 
known fact has been reiterated. Peptide sequence 2 has presented good evidence that 
structure does contribute to binding of DNA. One reason peptide sequence 2 is so much 
more structured than peptide sequence 1 is due to its combination of amino acids. 
Although both peptide sequences are comprised of many of the same amino acids, the 
order in which the amino acids are coupled in the sequence is very important. In peptide 
sequence 1, more side chain interactions between amino acids such as arginine and 
phenylalanine and lysine and glutamine cause more random coil, while in peptide 
sequence 2, lysine and tryptophan interact causing a more structured peptide. Although 
DNA binding studies have not yet been completed for peptide sequence 1, it is suspected 
that once completed the results will show better DNA binding with peptide sequence 2, 
due to sequence 2 being more structured than sequence 1.  
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Future work could be done on this project to further our knowledge of NF-κB 
peptide mimics and DNA binding. Once DNA binding has been completed for peptide 
sequence 1, further analysis of these peptides and others will be studied. The binding of 
these peptides to the kB DNA sequence will be compared to the binding to different 
DNA sequences to determine if different sequences are selective in binding. Additionally, 
other DNA binding molecules will be examined in order to further analyze selectivity for 
specific sequences. Finally, other peptide sequences will be synthesized, purified, and 
examined in order to further enhance the knowledge of how proteins bind to DNA.  
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